Published in Genes Dev on August 01, 2008
Single-cell NF-kappaB dynamics reveal digital activation and analogue information processing. Nature (2010) 5.27
Encoding and decoding cellular information through signaling dynamics. Cell (2013) 2.96
Information transduction capacity of noisy biochemical signaling networks. Science (2011) 2.95
A20: central gatekeeper in inflammation and immunity. J Biol Chem (2008) 2.83
A systems analysis identifies a feedforward inflammatory circuit leading to lethal influenza infection. Cell (2013) 2.38
Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr Rev (2009) 1.88
A single NFκB system for both canonical and non-canonical signaling. Cell Res (2010) 1.88
Functional roles of pulsing in genetic circuits. Science (2013) 1.84
miR-146a controls the resolution of T cell responses in mice. J Exp Med (2012) 1.81
Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol (2011) 1.77
Population robustness arising from cellular heterogeneity. Proc Natl Acad Sci U S A (2010) 1.66
Kinetic control of negative feedback regulators of NF-kappaB/RelA determines their pathogen- and cytokine-receptor signaling specificity. Proc Natl Acad Sci U S A (2009) 1.56
Understanding the temporal codes of intra-cellular signals. Curr Opin Genet Dev (2010) 1.48
Tumor necrosis factor induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages. Nat Immunol (2011) 1.46
A genetic algorithm-based Boolean delay model of intracellular signal transduction in inflammation. BMC Bioinformatics (2011) 1.39
Immunobiotic Lactobacillus jensenii elicits anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the Toll-like receptor signaling pathway. Infect Immun (2011) 1.38
Lessons from mathematically modeling the NF-κB pathway. Immunol Rev (2012) 1.22
Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65. Nucleic Acids Res (2011) 1.16
Modulation of Intestinal TLR4-Inflammatory Signaling Pathways by Probiotic Microorganisms: Lessons Learned from Lactobacillus jensenii TL2937. Front Immunol (2014) 1.15
Immunobiotic Lactobacillus jensenii modulates the Toll-like receptor 4-induced inflammatory response via negative regulation in porcine antigen-presenting cells. Clin Vaccine Immunol (2012) 1.15
The regulatory logic of the NF-kappaB signaling system. Cold Spring Harb Perspect Biol (2010) 1.13
Dimerization and ubiquitin mediated recruitment of A20, a complex deubiquitinating enzyme. Immunity (2013) 1.13
TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis. J Invest Dermatol (2011) 1.10
Regulation of NF-κB by TNF family cytokines. Semin Immunol (2014) 1.06
Switching of the relative dominance between feedback mechanisms in lipopolysaccharide-induced NF-κB signaling. Sci Signal (2014) 1.05
Computational modeling of mammalian signaling networks. Wiley Interdiscip Rev Syst Biol Med (2010) 1.04
Inhibition of IkappaB kinase-beta protects dopamine neurons against lipopolysaccharide-induced neurotoxicity. J Pharmacol Exp Ther (2010) 1.03
EphA2 activation promotes the endothelial cell inflammatory response: a potential role in atherosclerosis. Arterioscler Thromb Vasc Biol (2012) 1.02
De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF. Cell Death Differ (2011) 1.02
Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification. Endocr Metab Immune Disord Drug Targets (2009) 1.01
Protein kinase PKR amplification of interferon β induction occurs through initiation factor eIF-2α-mediated translational control. J Biol Chem (2012) 1.00
Immunoregulatory effect of bifidobacteria strains in porcine intestinal epithelial cells through modulation of ubiquitin-editing enzyme A20 expression. PLoS One (2013) 0.99
High-throughput, single-cell NF-κB dynamics. Curr Opin Genet Dev (2010) 0.96
Tunable signal processing through a kinase control cycle: the IKK signaling node. Biophys J (2013) 0.94
IκBε is a key regulator of B cell expansion by providing negative feedback on cRel and RelA in a stimulus-specific manner. J Immunol (2014) 0.94
The transcription factor DREAM represses the deubiquitinase A20 and mediates inflammation. Nat Immunol (2014) 0.92
Network dynamics determine the autocrine and paracrine signaling functions of TNF. Genes Dev (2014) 0.90
Dual delayed feedback provides sensitivity and robustness to the NF-κB signaling module. PLoS Comput Biol (2013) 0.90
Spontaneous NF-κB activation by autocrine TNFα signaling: a computational analysis. PLoS One (2013) 0.89
NF-κB repression by PIAS3 mediated RelA SUMOylation. PLoS One (2012) 0.87
Hit-and-run stimulation: a novel concept to reactivate latent HIV-1 infection without cytokine gene induction. J Virol (2010) 0.85
PPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1. Biochim Biophys Acta (2011) 0.84
Noise decomposition of intracellular biochemical signaling networks using nonequivalent reporters. Proc Natl Acad Sci U S A (2014) 0.84
Stimulus-selective crosstalk via the NF-κB signaling system reinforces innate immune response to alleviate gut infection. Elife (2015) 0.82
NF-κB oscillations translate into functionally related patterns of gene expression. Elife (2016) 0.82
A systems biology approach to suppress TNF-induced proinflammatory gene expressions. Cell Commun Signal (2013) 0.82
IκBβ enhances the generation of the low-affinity NFκB/RelA homodimer. Nat Commun (2015) 0.82
Accurate encoding and decoding by single cells: amplitude versus frequency modulation. PLoS Comput Biol (2015) 0.81
Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation. J Biol Chem (2014) 0.81
Quantitative characterization and analysis of the dynamic NF-κB response in microglia. BMC Bioinformatics (2011) 0.81
Redefining Signaling Pathways with an Expanding Single-Cell Toolbox. Trends Biotechnol (2016) 0.80
Overexpression of heat shock protein 72 attenuates NF-κB activation using a combination of regulatory mechanisms in microglia. PLoS Comput Biol (2014) 0.80
MCPIP1 Endoribonuclease Activity Negatively Regulates Interleukin-17-Mediated Signaling and Inflammation. Immunity (2015) 0.80
Anatomy of a negative feedback loop: the case of IκBα. J R Soc Interface (2015) 0.79
Interleukin-1 and interferon-γ orchestrate β-glucan-activated human dendritic cell programming via IκB-ζ modulation. PLoS One (2014) 0.79
Preclinical Assessment of Mutant Human TRIM5α as an Anti-HIV-1 Transgene. Hum Gene Ther (2015) 0.79
Clustering reveals limits of parameter identifiability in multi-parameter models of biochemical dynamics. BMC Syst Biol (2015) 0.79
Effect of pulsed electromagnetic field on inflammatory pathway markers in RAW 264.7 murine macrophages. J Inflamm Res (2013) 0.78
Signal transduction controls heterogeneous NF-κB dynamics and target gene expression through cytokine-specific refractory states. Nat Commun (2016) 0.78
Effects of IRF5 lupus risk haplotype on pathways predicted to influence B cell functions. J Biomed Biotechnol (2012) 0.77
Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-κB activation. J Virol (2013) 0.77
A Systems Biology Study on NFκB Signaling in Primary Mouse Hepatocytes. Front Physiol (2012) 0.76
Glucocorticoid and TNF signaling converge at A20 (TNFAIP3) to repress airway smooth muscle cytokine expression. Am J Physiol Lung Cell Mol Physiol (2016) 0.76
A20 overexpression inhibits lipopolysaccharide-induced NF-κB activation, TRAF6 and CD40 expression in rat peritoneal mesothelial cells. Int J Mol Sci (2014) 0.75
Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression. J Cell Physiol (2016) 0.75
NF-κB signalling and cell fate decisions in response to a short pulse of tumour necrosis factor. Sci Rep (2016) 0.75
Regulation of NF-κB Oscillation by Nuclear Transport: Mechanisms Determining the Persistency and Frequency of Oscillation. PLoS One (2015) 0.75
MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD. JCI Insight (2017) 0.75
Kelch-like Protein 21 (KLHL21) Targets IκB Kinase-β to Regulate Nuclear Factor κ-Light Chain Enhancer of Activated B Cells (NF-κB) Signaling Negatively. J Biol Chem (2016) 0.75
Interrogation of inhibitor of nuclear factor κB α/nuclear factor κB (IκBα/NF-κB) negative feedback loop dynamics: from single cells to live animals in vivo. J Biol Chem (2012) 0.75
Importins promote high-frequency NF-κB oscillations increasing information channel capacity. Biol Direct (2016) 0.75
T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways. J Immunol (2017) 0.75
From molecular to modular cell biology. Nature (1999) 23.51
Shared principles in NF-kappaB signaling. Cell (2008) 20.96
Missing pieces in the NF-kappaB puzzle. Cell (2002) 17.83
Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science (2002) 17.71
The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science (2002) 13.86
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature (2004) 12.41
IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science (1997) 11.89
TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature (2001) 11.84
Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science (2000) 10.98
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol (2004) 9.42
Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science (2004) 8.44
Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol (2006) 7.25
Robustness of cellular functions. Cell (2004) 6.65
Circuitry of nuclear factor kappaB signaling. Immunol Rev (2006) 6.49
Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science (1999) 5.95
Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol (1985) 5.38
Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell (1993) 5.37
Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol (1999) 5.36
Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science (2005) 5.14
Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev (1995) 4.38
The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev (1993) 4.23
The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci U S A (1996) 4.03
Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J (2003) 3.93
Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity (2004) 3.26
The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity (2008) 3.19
Two waves of nuclear factor kappaB recruitment to target promoters. J Exp Med (2001) 3.03
Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20. J Exp Med (2008) 2.80
IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol Cell Biol (1996) 2.62
IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression. J Cell Biol (2006) 2.38
Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem (1990) 2.37
The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc Natl Acad Sci U S A (1998) 2.26
A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity. Mol Syst Biol (2007) 2.13
Transient IkappaB kinase activity mediates temporal NF-kappaB dynamics in response to a wide range of tumor necrosis factor-alpha doses. J Biol Chem (2005) 2.08
Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. Oncogene (1999) 1.93
A TNF-induced gene expression program under oscillatory NF-kappaB control. BMC Genomics (2005) 1.92
Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene (1999) 1.71
A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression. Nat Med (2008) 1.65
The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genes. Proc Natl Acad Sci U S A (2007) 1.45
Nuclear factor kappaB: a potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc Res (2004) 1.42
Extracellular TNFR1 release requires the calcium-dependent formation of a nucleobindin 2-ARTS-1 complex. J Biol Chem (2006) 1.36
Continuous internalization of tumor necrosis factor receptors in a human myosarcoma cell line. J Biol Chem (1988) 1.19
A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-kappaB. J Cell Sci (2008) 1.18
The role of TNF and its family members in inflammation and cancer: lessons from gene deletion. Curr Drug Targets Inflamm Allergy (2002) 1.16
Dynamic stability of steady states and static stabilization in unbranched metabolic pathways. J Math Biol (1982) 0.88
Signaling by tumor necrosis factor receptors: pathways, paradigms and targets for therapeutic modulation. Int Rev Immunol (1999) 0.79
NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A (2006) 21.58
Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science (2002) 17.71
The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science (2002) 13.86
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature (2004) 12.41
Chimeric nucleases stimulate gene targeting in human cells. Science (2003) 12.12
MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A (2007) 11.42
The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol (2004) 9.42
Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol (2010) 7.75
MicroRNAs: new regulators of immune cell development and function. Nat Immunol (2008) 6.96
Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell (2011) 6.82
Circuitry of nuclear factor kappaB signaling. Immunol Rev (2006) 6.49
A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell (2009) 6.26
Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci U S A (2002) 6.09
Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med (2008) 5.97
Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science (2010) 5.94
Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J Exp Med (2002) 5.64
Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A (2009) 5.30
Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science (2005) 5.14
Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science (2005) 4.83
Medicine. The need for a global HIV vaccine enterprise. Science (2003) 4.70
MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity (2010) 4.65
Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell (2010) 4.57
One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. Cell (2004) 4.53
Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev (2003) 4.40
Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol (2002) 4.36
Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nat Genet (2008) 4.33
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell (2005) 4.30
Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science (2010) 4.03
Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J (2003) 3.93
The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol (2009) 3.85
Antibody-based protection against HIV infection by vectored immunoprophylaxis. Nature (2011) 3.80
miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med (2011) 3.78
microRNA regulation of inflammatory responses. Annu Rev Immunol (2012) 3.47
NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci (2003) 3.40
A fourth IkappaB protein within the NF-kappaB signaling module. Cell (2007) 3.34
The ubiquitin-editing enzyme A20 restricts nucleotide-binding oligomerization domain containing 2-triggered signals. Immunity (2008) 3.19
Two pathways to NF-kappaB. Mol Cell (2002) 3.12
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature (2011) 3.08
MicroRNAs and immunity: tiny players in a big field. Immunity (2007) 3.01
Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell (2012) 2.94
CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex. EMBO J (2002) 2.90
Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20. J Exp Med (2008) 2.80
Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell (2004) 2.79
Coordinate expression and trans presentation of interleukin (IL)-15Ralpha and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis. J Exp Med (2004) 2.78
NF-kappaB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci U S A (2011) 2.74
Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells. Proc Natl Acad Sci U S A (2005) 2.68
Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis--CREB and NF-kappaB as key regulators. Immunity (2005) 2.56
Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J Exp Med (2003) 2.51
Cytokines and autoimmunity. Nat Rev Immunol (2002) 2.51
MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematopoietic output. Proc Natl Acad Sci U S A (2010) 2.40
IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression. J Cell Biol (2006) 2.38
IL-15Ralpha chaperones IL-15 to stable dendritic cell membrane complexes that activate NK cells via trans presentation. J Exp Med (2008) 2.33
Direct, noncatalytic mechanism of IKK inhibition by A20. Mol Cell (2011) 2.32
IkappaB kinase beta phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway. Mol Cell Biol (2007) 2.31
Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc Natl Acad Sci U S A (2007) 2.30
Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. Genes Dev (2010) 2.26
CK2 Is a C-Terminal IkappaB Kinase Responsible for NF-kappaB Activation during the UV Response. Mol Cell (2003) 2.23
Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc Natl Acad Sci U S A (2008) 2.20
Cutting edge: innate immunity conferred by B cells is regulated by caspase-8. J Immunol (2005) 2.18
Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance. J Immunol (2003) 2.13
A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity. Mol Syst Biol (2007) 2.13
Regulation of NF-kappaB activity through lysine monomethylation of p65. Proc Natl Acad Sci U S A (2009) 2.10
Transient IkappaB kinase activity mediates temporal NF-kappaB dynamics in response to a wide range of tumor necrosis factor-alpha doses. J Biol Chem (2005) 2.08
IL-15R alpha expression on CD8+ T cells is dispensable for T cell memory. Proc Natl Acad Sci U S A (2003) 2.07
Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat Biotechnol (2008) 2.05
Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem (2005) 2.01
Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks. Mol Cell Biol (2003) 2.01
Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors. Mol Ther (2006) 1.99
The ubiquitin modifying enzyme A20 restricts B cell survival and prevents autoimmunity. Immunity (2010) 1.97
A single NFκB system for both canonical and non-canonical signaling. Cell Res (2010) 1.88
Physiological functions for brain NF-kappaB. Trends Neurosci (2005) 1.85
Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J Immunol (2004) 1.85
Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity (2013) 1.83
miR-146a controls the resolution of T cell responses in mice. J Exp Med (2012) 1.81
NF-kappaB dictates the degradation pathway of IkappaBalpha. EMBO J (2008) 1.81
Comment on "Oscillations in NF-kappaB signaling control the dynamics of gene expression". Science (2005) 1.79
Understanding NF-kappaB signaling via mathematical modeling. Mol Syst Biol (2008) 1.79
Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis. Nat Immunol (2011) 1.77
Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets. Immunity (2009) 1.75
Sam68 is required for both NF-κB activation and apoptosis signaling by the TNF receptor. Mol Cell (2011) 1.73
ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development. Nature (2008) 1.72
Targeting lentiviral vectors to specific cell types in vivo. Proc Natl Acad Sci U S A (2006) 1.71
Broad protection against influenza infection by vectored immunoprophylaxis in mice. Nat Biotechnol (2013) 1.71
MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity (2010) 1.70
MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol Med (2013) 1.70
NEMO ensures signaling specificity of the pleiotropic IKKβ by directing its kinase activity toward IκBα. Mol Cell (2012) 1.68
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy. Cancer Discov (2013) 1.68
IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response. Nature (2010) 1.68